Patents by Inventor David R. Swanson

David R. Swanson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11960683
    Abstract: A display system for sensing a finger of a user applied to the display system includes a display panel; a sensor for sensing the finger; a sensing light source configured to emit a first light having a first wavelength W1; and a reflective polarizer disposed between the display panel and the sensor. For a substantially normally incident light, an optical transmittance of the reflective polarizer versus wavelength for a first polarization state has a band edge such that for a first wavelength range extending from a smaller wavelength L1 to a greater wavelength L2 and including W1, where 30 nm?L2?L1?50 nm and L1 is greater than and within about 20 nm of a wavelength L3 corresponding to an optical transmittance of about 50% along the band edge, the optical transmittance has an average of greater than about 75%.
    Type: Grant
    Filed: May 4, 2021
    Date of Patent: April 16, 2024
    Assignee: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: Bharat R. Acharya, Robert D. Taylor, Joseph P. Attard, Benjamin J. Forsythe, David T. Yust, Matthew E. Sousa, Jason S. Petaja, Anthony M. Renstrom, William Blake Kolb, Matthew S. Cole, Matthew S. Stay, Matthew R. D. Smith, Jeremy O. Swanson, Tri D. Pham, David A. Rosen, Qunyi Chen, Lisa A. DeNicola, Quinn D. Sanford, Carl A. Stover, Lin Zhao, Gilles J. Benoit
  • Publication number: 20240111263
    Abstract: Systems, methods, and non-transitory computer-readable media for optimization and autoconfiguration of edge processing devices are disclosed. A cloud computing system can receive a request to configure a target building device. The cloud computing system can identify, based on the target building device, a connector template for the target building device. The connector template can include one or more parameters for a connector component configured to cause the target building device to communicate with the cloud computing system. cloud computing system can generate the connector component for the target building device based on the one or more parameters. cloud computing system can deploy the connector component to the target building device.
    Type: Application
    Filed: September 29, 2023
    Publication date: April 4, 2024
    Inventors: Murali R. Namburi, David R. Koberstein, Manish K. Kalbande, Sastry K. Malladi, Trent M. Swanson, Abu Bakr Khan, Eric G. Lang, Miguel Galvez, David A. Duncan, Bryan Skene, Nicholas Marrone
  • Patent number: 11947845
    Abstract: A computing device includes: a housing configured to receive a supply of print media; a print head supported by the housing; a wireless communications subsystem supported by the housing; a controller supported by the housing, the controller configured to: control the communications subsystem to detect a data collection device; obtain, from the data collection device via the communications subsystem, monitoring data collected by the data collection device indicative of an environmental condition; transmit the monitoring data; receive a command based on the monitoring data; and control the print head to apply indicia to the print media according to the command.
    Type: Grant
    Filed: May 16, 2023
    Date of Patent: April 2, 2024
    Assignee: Zebra Technologies Corporation
    Inventors: Robert A. Grom, David A. Langevin, Ujjaval C. Patel, Craig M. Swanson, Gerard R. Corriveau
  • Patent number: 5326571
    Abstract: A dosage form is disclosed comprising a wall surrounding a compartment, which comprises a first composition comprising a carboxymethylcellulose and a second composition comprising a higher molecular weight carboxymethylcellulose. The first composition comprises a dosage amount of drug that delivers from the dosage form at a controlled rate over time.
    Type: Grant
    Filed: September 4, 1992
    Date of Patent: July 5, 1994
    Assignee: ALZA Corporation
    Inventors: Jeri D. Wright, Brian L. Barclay, David R. Swanson
  • Patent number: 5208037
    Abstract: A dosage form is disclosed comprising a wall surrounding a compartment, which comprises a first composition comprising a carboxymethylcellulose and a second composition comprising a higher molecular weigh carboxymethylcellulose. The first composition comprises a dosage amount of drug that delivers from the dosage form at a controlled rate over time.
    Type: Grant
    Filed: April 22, 1991
    Date of Patent: May 4, 1993
    Assignee: ALZA Corporation
    Inventors: Jeri D. Wright, Brian L. Barclay, David R. Swanson
  • Patent number: 5186942
    Abstract: A dosage form is disclosed comprising a member selected from the group consisting of nicardipine and its pharmaceutically acceptable salts for administering to a patient in need of cardio-vascular therapy.
    Type: Grant
    Filed: November 18, 1991
    Date of Patent: February 16, 1993
    Assignee: ALZA Corporation
    Inventors: Joseph C. Deters, David R. Swanson, Stephen C. DeRosa
  • Patent number: 5096716
    Abstract: A dosage form is disclosed comprising a member selected from the group consisting of nicardipine and its pharmaceutically acceptable salts for administering to a patient in need of cardiovascular therapy.
    Type: Grant
    Filed: May 18, 1990
    Date of Patent: March 17, 1992
    Assignee: ALZA Corporation
    Inventors: Joseph C. Deters, David R. Swanson, Stephen C. DeRosa
  • Patent number: 5030456
    Abstract: An osmotic device is disclosed comprising a first composition, and a second composition with the beneficial drug isradipine in the first composition.
    Type: Grant
    Filed: April 30, 1990
    Date of Patent: July 9, 1991
    Assignee: ALZA Corporation
    Inventors: Atul D. Ayer, David R. Swanson, Anthony L. Kuczynski
  • Patent number: 4950486
    Abstract: An osmotic device is disclosed comprising a first composition, and a second composition with the beneficial drug isradipine in the first composition.
    Type: Grant
    Filed: November 7, 1988
    Date of Patent: August 21, 1990
    Assignee: Alza Corporation
    Inventors: Atul D. Ayer, David R. Swanson, Anthony L. Kuczynski
  • Patent number: 4946687
    Abstract: An osmotic device is disclosed comprising a first composition, and a second composition with the beneficial drug isradipine in the first composition.
    Type: Grant
    Filed: November 7, 1988
    Date of Patent: August 7, 1990
    Assignee: Alza Corporation
    Inventors: Atul D. Ayer, David R. Swanson, Anthony L. Kuczynski
  • Patent number: 4837111
    Abstract: An osmotic dosage system is disclosed for delivering the therapeutically beneficial drug doxazosin to an environment of use over time.
    Type: Grant
    Filed: March 21, 1988
    Date of Patent: June 6, 1989
    Assignee: ALZA Corporation
    Inventors: Joseph C. Deters, Patrick S. L. Wong, Brian L. Barclay, Felix Theeuwes, David R. Swanson
  • Patent number: 4816263
    Abstract: An osmotic device is disclosed comprising a first composition, and a second composition with the beneficial drug isradipine in the first composition.
    Type: Grant
    Filed: October 2, 1987
    Date of Patent: March 28, 1989
    Assignee: ALZA Corporation
    Inventors: Atul D. Ayer, David R. Swanson, Anthony L. Kuczynski